Ohio State University researchers have found that the peptide-based molecule known as HN1 could be used for optical and nuclear imaging, potentially improving detection and removal of cancerous lesions. Labeled with a radiopharmaceutical, HN1 could help detect cancer, while a fluorescent agent could be appended to it, providing real-time data for surgical excisions.

Related Summaries